Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons

NCT00001060 ·Status: COMPLETED ·Phase: PHASE1

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

NCT00005779 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects

NCT01428596 ·Status: UNKNOWN ·Phase: PHASE1

Safety Study of IL-7 in HIV-infected Patients (Inspire)

NCT00477321 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults

NCT00054860 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose

NCT00001056 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Trial to Evaluate CAP256V2LS in Healthy Adults

NCT04408963 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV

NCT00001105 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex

NCT00000675 ·Status: COMPLETED ·Phase: PHASE1

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

NCT00148824 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

NCT00114699 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients

NCT00055185 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Prophylactic HIV Vaccine Candidate

NCT05863585 ·Status: UNKNOWN ·Phase: PHASE1

Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies

NCT00311688 ·Status: COMPLETED

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex

NCT00002004 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

NCT00000889 ·Status: COMPLETED ·Phase: PHASE2

Selection of a Protective T Cell-based HIV-1/FIV Vaccine

NCT02389595 ·Status: ACTIVE_NOT_RECRUITING

A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

NCT00000949 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

NCT00120185 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants

NCT05959707 ·Status: SUSPENDED ·Phase: PHASE1

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

NCT00000755 ·Status: COMPLETED ·Phase: PHASE1

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

NCT00000825 ·Status: COMPLETED ·Phase: PHASE2

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

NCT00119873 ·Status: COMPLETED ·Phase: PHASE1

A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

NCT00004579 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells

NCT03856996 ·Status: COMPLETED ·Phase: PHASE1